CAITLIN HIBBETT: Open Payments
NPI 1497530257 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 67 payments from 12 companies in 2025. Trend: 2023 $89 · 2024 $957 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $277 |
| Otsuka America Pharmaceutical, Inc. | 10 | $164 |
| Corium, LLC | 7 | $155 |
| Alkermes, Inc. | 7 | $155 |
| ABBVIE INC. | 13 | $144 |
| Axsome Therapeutics, Inc. | 6 | $139 |
| Almatica Pharma LLC | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $15 |
Products named: CAPLYTA, Azstarys, ARISTADA, VRAYLAR, Auvelity, ABILIFY MAINTENA, LOREEV XR, REXULTI.
Industry payments across AL — which companies pay providers there.
